BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27525643)

  • 1. Torque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation.
    Schiemann M; Puchhammer-Stöckl E; Eskandary F; Kohlbeck P; Rasoul-Rockenschaub S; Heilos A; Kozakowski N; Görzer I; Kikić Ž; Herkner H; Böhmig GA; Bond G
    Transplantation; 2017 Feb; 101(2):360-367. PubMed ID: 27525643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial.
    Doberer K; Haupenthal F; Nackenhorst M; Bauernfeind F; Dermuth F; Eigenschink M; Schiemann M; Kläger J; Görzer I; Eskandary F; Reindl-Schwaighofer R; Kikić Ž; Böhmig G; Strassl R; Regele H; Puchhammer-Stöckl E; Bond G
    Transplantation; 2021 Sep; 105(9):2112-2118. PubMed ID: 33587432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients.
    Strassl R; Doberer K; Rasoul-Rockenschaub S; Herkner H; Görzer I; Kläger JP; Schmidt R; Haslacher H; Schiemann M; Eskandary FA; Kikić Ž; Reindl-Schwaighofer R; Puchhammer-Stöckl E; Böhmig GA; Bond G
    J Infect Dis; 2019 May; 219(12):1934-1939. PubMed ID: 30668796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-A prospective observational trial.
    Doberer K; Schiemann M; Strassl R; Haupenthal F; Dermuth F; Görzer I; Eskandary F; Reindl-Schwaighofer R; Kikić Ž; Puchhammer-Stöckl E; Böhmig GA; Bond G
    Am J Transplant; 2020 Aug; 20(8):2081-2090. PubMed ID: 32034850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT.
    Haupenthal F; Rahn J; Maggi F; Gelas F; Bourgeois P; Hugo C; Jilma B; Böhmig GA; Herkner H; Wolzt M; Doberer K; Vossen M; Focosi D; Neuwirt H; Banas M; Banas B; Budde K; Viklicky O; Malvezzi P; Rostaing L; Rotmans JI; Bakker SJL; Eller K; Cejka D; Pérez AM; Rodriguez-Arias D; König F; Bond G;
    Trials; 2023 Mar; 24(1):213. PubMed ID: 36949445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective cohort study of Torque Teno Virus (TTV) viral load kinetics and the association with graft rejection in renal transplant patients.
    Reyes NS; Laham G; Boccia N; García G; Jara R; Hermida E; Ricarte C; Diaz C; Soler Pujol G; Poletta FA; Echavarria M
    J Clin Virol; 2023 Aug; 165():105501. PubMed ID: 37379781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torque Teno Virus Is Associated With the State of Immune Suppression Early After Liver Transplantation.
    Ruiz P; Martínez-Picola M; Santana M; Muñoz J; Pérez-Del-Pulgar S; Koutsoudakis G; Sastre L; Colmenero J; Crespo G; Navasa M
    Liver Transpl; 2019 Feb; 25(2):302-310. PubMed ID: 30375165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No correlation between Torque Teno virus viral load and BK virus replication after kidney transplantation.
    Handala L; Descamps V; Morel V; Castelain S; François C; Duverlie G; Helle F; Brochot E
    J Clin Virol; 2019 Jul; 116():4-6. PubMed ID: 30986626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients.
    Strassl R; Schiemann M; Doberer K; Görzer I; Puchhammer-Stöckl E; Eskandary F; Kikic Ž; Gualdoni GA; Vossen MG; Rasoul-Rockenschaub S; Herkner H; Böhmig GA; Bond G
    J Infect Dis; 2018 Sep; 218(8):1191-1199. PubMed ID: 30007341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection.
    van Rijn AL; Wunderink HF; Sidorov IA; de Brouwer CS; Kroes AC; Putter H; de Vries AP; Rotmans JI; Feltkamp MC
    J Clin Virol; 2021 Jul; 140():104871. PubMed ID: 34089977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial.
    Eskandary F; Bond G; Schwaiger E; Kikic Z; Winzer C; Wahrmann M; Marinova L; Haslacher H; Regele H; Oberbauer R; Böhmig GA
    Trials; 2014 Apr; 15():107. PubMed ID: 24708575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.
    Eskandary F; Bond G; Kozakowski N; Regele H; Marinova L; Wahrmann M; Kikić Ž; Haslacher H; Rasoul-Rockenschaub S; Kaltenecker CC; König F; Hidalgo LG; Oberbauer R; Halloran PF; Böhmig GA
    Transplantation; 2017 Mar; 101(3):631-641. PubMed ID: 27120452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torque teno virus load as marker of rejection and infection in solid organ transplantation - A systematic review and meta-analysis.
    van Rijn AL; Roos R; Dekker FW; Rotmans JI; Feltkamp M
    Rev Med Virol; 2023 Jan; 33(1):e2393. PubMed ID: 36056751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of Torque Teno Virus in hemodialysis and renal transplant patients in Australia: A cross-sectional study.
    Davis JS; Chu G; Pathinayake P; Jones D; Giffard P; Macera L; Choi P; Bartlett NW
    Transpl Infect Dis; 2020 Oct; 22(5):e13400. PubMed ID: 33462980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking, Alcohol Intake and Torque Teno Virus in Stable Kidney Transplant Recipients.
    Doorenbos CSE; Jonker J; Hao J; Gore EJ; Kremer D; Knobbe TJ; de Joode AAE; Sanders JSF; Thaunat O; Niesters HGM; Van Leer-Buter CC; Bakker SJL
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
    Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
    Gupta G; Abu Jawdeh BG; Racusen LC; Bhasin B; Arend LJ; Trollinger B; Kraus E; Rabb H; Zachary AA; Montgomery RA; Alachkar N
    Transplantation; 2014 Jun; 97(12):1240-6. PubMed ID: 24937198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of plasma Torque Teno viral load applying a CE-certified PCR for risk stratification of rejection and infection post kidney transplantation.
    Görzer I; Haupenthal F; Maggi F; Gelas F; Kulifaj D; Brossault L; Puchhammer-Stöckl E; Bond G
    J Clin Virol; 2023 Jan; 158():105348. PubMed ID: 36463684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torque-teno virus for the prediction of graft rejection and infection disease after kidney transplantation: A systematic review and meta-analysis.
    Zeng J; Tang Y; Lin T; Song T
    J Med Virol; 2023 Mar; 95(3):e28677. PubMed ID: 36929741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.